NPCE News and Press, Neuropace Inc. From 05/13/25

2025-05-13 22:34:17 ET More on NeuroPace NeuroPace, Inc. (NPCE) Q1 2025 Earnings Call Transcript NeuroPace, Inc. 2025 Q1 - Results - Earnings Call Presentation NeuroPace, Inc. (NPCE) Q4 2024 Earnings Call Transcript NeuroPace expects minimal impact of tariffs...

2025-05-13 18:48:09 ET NeuroPace, Inc. (NPCE) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 10.06%. The average open to low on the day of earnings was -13.42%. The average open to clos...

2025-05-13 18:43:09 ET NeuroPace, Inc. (NPCE) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in NPCE stock price following earnings has averaged ±3.22% , with a median of 2.83%. The ...

2025-05-13 18:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

-- Reported record quarterly revenue of $22.5 million in Q1 2025, driven by increasing market demand for core RNS System products -- -- Increased full-year 2025 revenue guidance to $93 to $97 million -- -- On track to announce topline data from the NAUTILUS pivotal study in the se...

2025-04-17 23:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2025-04-14 16:21:17 ET More on NeuroPace NeuroPace, Inc. (NPCE) Q4 2024 Earnings Call Transcript NeuroPace, Inc. 2024 Q4 - Results - Earnings Call Presentation Stryker, Boston Scientific down as new tariffs impact medtech industry NeuroPace refocuses product ...

-- Minimal expected impact to operations and financial results -- -- Company to report first quarter 2025 financial results on May 13, 2025 -- MOUNTAIN VIEW, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming t...

Three-year data from the largest FDA-reviewed prospective neuromodulation study of safety and effectiveness in drug-resistant focal epilepsy 1 Long-term seizure reduction with a median reduction of 82% at 3 years. Seizure freedom with 42% of patients remaining seizure free for 6+ mont...

2025-04-03 12:42:10 ET More on Boston Scientific, Stryker Boston Scientific: Bright Future, Rather Pricey Boston Scientific Corporation (BSX) TD Cowen 45th Annual Healthcare Conference (Transcript) Stryker Corporation (SYK) Citi's 2025 Unplugged Medtech and Life Scie...